Answer
No, rabeprazole 40 mg once daily co-administered with fruquintinib did not cause clinically meaningful changes in fruquintinib exposure measured by AUC.
Sources for this answer
- FRUZAQLA 1 mg hard capsulesTakeda UK Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 3Document updated
Sources checked